SK hynix (KRX:000660) ADR Soars, U.S. Premium Hits 37%

SK hynix (KRX:000660) ADR Soars, U.S. Premium Hits 37%

SEOUL, August 5, 2026, 02:06 KST

  • Receipts traded on Nasdaq were up 6.39% at $151.84 as of 13:05 EDT. Shares in Seoul ended the session 0.64% higher at ₩1.577 million.
  • After accounting for the depositary ratio and exchange rate, the U.S. receipt suggested a common-share value of ₩2.168 million, 37.5% higher than the price in Seoul.
  • SK hynix saw its DRAM market share drop by 13 percentage points to 26% in the second quarter, leaving Micron trailing by just one percentage point.

Shares of SK hynix Inc. traded in the U.S. rose 6.4% on Tuesday after six brokerages initiated buy-equivalent coverage of the AI-memory company. The firm’s main Seoul-listed stock ended the session up 0.6%.

Stock chart for KRX:000660

Seoul was closed for the session, while Nasdaq stayed open.

The split is more significant than the headline gain. This indicates that Wall Street is adjusting the value of access to SK hynix at a quicker pace than the underlying Korean shares.

One U.S. depositary share is equivalent to one-tenth of a Korean common share. Based on an exchange rate of ₩1,428.03 to the dollar, the U.S. listing suggested a value of ₩2.168 million per Korean common share. This resulted in a premium of 37.5%.

Cross-listing measureSeoul ordinary shareNasdaq depositary share
TickerKRX:000660NASDAQ:SKHY
Latest price₩1,577,000$151.84
Session change+0.64%+6.39%
Implied common-share value₩1,577,000₩2,168,313
Premium to Seoul37.5%
Market status at datelineClosedOpen
Change from $149 U.S. offer+1.9%

Ten depositary shares are equal to one common share. The figures are based on the most recent currency and market data available.

The premium exists due to both structural and sentimental factors. Korean regulations restrict the issuance of new depositary shares from domestic stock, preventing the standard arbitrage method.

The setup mostly operates in a single direction. American investors are allowed to cancel their receipts in exchange for the Korean shares underneath. However, local investors do not have the same freedom to issue new U.S. receipts and take advantage of the premium.

Trading activity locally has been turbulent. Across the last five sessions, daily absolute movements reached a combined 54.6 percentage points. Despite this volatility, SK hynix ended just 1.7% higher than its July 28 close.

Initiations on Tuesday reflected broad bullish sentiment. Rosenblatt assigned the top price target at $320. William Blair established a $260 target, and Stifel Financial Corp. placed its target at $240.

Research firmRatingU.S. targetDerived upside
Rosenblatt SecuritiesBuy-equivalent$320110.7%
William BlairOutperform$26071.2%
Stifel Financial Buy$24058.1%

Upside is based on the intraday price of $151.84. This figure will fluctuate as the market moves.

William Blair stated that a U.S. listing may allow SK hynix to “re-rate closer” to Micron Technology Inc. . However, the valuation case faces a hurdle, as U.S. investors are currently subject to a 37.5% access premium. Reuters

The positive coverage came after a tough reaction to the earnings report. While second-quarter revenue and operating profit reached all-time highs, both fell short of LSEG forecasts. Some revenue was deferred to future periods due to postponed HBM4 deliveries.

Q2 2026 measureReportedComparisonInvestor read-through
Revenue₩79.3 trillion₩84 trillion LSEG estimate5.6% below consensus; up 257% from previous year
Operating profit₩60.5 trillion₩64 trillion LSEG estimate5.5% under forecast; surged by over six times
Net profit₩93.9 trillionNo cited consensusGrew by over 13 times
Investment gains₩63.3 trillionDrove net profit strength
2026 capital spendingHigh-₩40 trillion range₩30.2 trillion in 2025Significant expansion in capacity and equipment

Indicators of demand continued to be robust. President Song Hyun-jong stated, “Major customers are still requesting more memory supply.” SK hynix has finalized negotiations for about 10 long-term supply contracts, most of which span five years. Reuters

Wider DRAM market figures are more concerning. Samsung Electronics Co. moved back into the top spot in the second quarter. SK hynix’s market share dropped to 26%, with Micron rising to 25%. China’s CXMT Corp. increased its share to 7%.

DRAM supplierQ2 2026 revenue shareYear-earlier comparison
Samsung Electronics 39%Back in lead position
SK hynix26%39%, decrease of 13 points
Micron Technology 25%22%, an increase of 3 points
CXMT Corp. 7%Under 1%, rose by at least 6 points

This raises the bar for investors. The premium reflects HBM leadership rather than overall DRAM supremacy. Its sustainability relies on successful HBM4 rollout and ongoing limited supply.

Credit and employment updates signal differing outlooks. Moody’s Corp. upgraded SK hynix to A3 from Baa1, highlighting robust cash flow. Meanwhile, management and union representatives entered a fifth session of discussions over bonuses. According to the latest Reuters coverage, no agreement has been reached.

The week begins with a catch-up test in Seoul. Investors will observe if domestic equities mirror Tuesday’s rally in the U.S. Focus will also be on the ADR premium, the timing of HBM4 shipments, and any developments in bonus negotiations.

Risks: Reduced pace in AI infrastructure investment, additional HBM4 postponements, expansion of Chinese production or labor disruptions may pressure prices and narrow the ADR premium. Alternatively, restricted supply or increased long-term customer agreements would likely have a positive effect.

TS2 TECH • EXTENDED COVERAGE

Further analysis

Could HBM4 performance help rebuild confidence following the Q2 shortfall?
Second-quarter revenue was ₩79.3 trillion, and operating profit stood at ₩60.5 trillion. Both were approximately 6% under LSEG estimates, though they marked record highs in absolute terms. Analysts attributed the shortfall to slower HBM4 shipments, postponing revenue recognition in the quarter. Mass shipments commenced in Q2 and are projected to increase during the second half. Execution remains the main focus. SK hynix Newsroom
Is Wall Street’s latest coverage backing a shift in valuation?
SKHY was last at $151.66 as of 16:50 UTC on August 4. On the same day, at least six brokerages initiated buy-equivalent ratings. The S&P Global poll of ten analysts showed an average target of $230, suggesting a potential gain of about 52%. Seoul-listed shares are valued at roughly 4.6 times projected 2026 earnings. Analyst price targets range from $152 to $355, reflecting a rare degree of uncertainty. Reuters
Can long-term contracts safeguard earnings while allowing for price gains?
SK hynix has secured multi-year deals with approximately 10 key customers. According to Reuters, the contracts generally cover five years and require deposits. These agreements help increase certainty around shipment volumes and shield the company from abrupt demand fluctuations. On the downside, the contract conditions could cap gains if memory prices climb sharply. SK hynix Newsroom
Is rapid expansion of capacity enough to prevent another oversupply of memory?
Management expects capital spending for 2026 to be in the high-₩40-trillion range, up from ₩30.2 trillion allocated in 2025. M15X output is ramping up, and Yongin Phase 1 is on track to launch in early 2027. Demand from customers continues to outstrip current supply capacity. There is increasing risk if a slowdown in AI investment occurs before the new capacity is fully utilized. SK hynix Newsroom
Could record cash result in higher returns for shareholders?
Net cash stood at ₩69.4 trillion by the end of the second quarter. However, ₩63.3 trillion in investment gains contributed to ₩93.9 trillion in net profit. Analysts attributed a large portion of these gains to Kioxia, though the company did not provide details. Seoul equities yield just 0.19%, leaving payout expectations highly sensitive. The company intends to announce its shareholder-return strategy later in 2026. SK hynix Newsroom

Leokadia Głogulska is a financial and technology journalist at TS2.tech, covering stocks, artificial intelligence, space technology and global market developments. She graduated from Wrocław University of Economics and Business and previously worked in financial analysis before moving into business journalism. Her reporting focuses on helping readers understand the market trends, companies and technologies shaping the global economy.

AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

Xylem

NYSE: XYL 94 / 100
#2 BUY

AerCap

NYSE: AER 92 / 100
#3 BUY ON WEAKNESS

Visa

NYSE: V 89 / 100
#4 BUY IN TRANCHES

Lennox

NYSE: LII 87 / 100
#5 ACCUMULATE

UPS

NYSE: UPS 84 / 100
View full portfolio
Editorial model selection. Not personalised advice.
Autonomix Medical (NASDAQ:AMIX) Shares Surge 400% Following Patent Update Linked to a 2025 Grant
Previous Story

Autonomix Medical (NASDAQ:AMIX) Shares Surge 400% Following Patent Update Linked to a 2025 Grant